Bank of New York Mellon
OTLK icon

Bank of New York Mellon’s Outlook Therapeutics OTLK Stock Holding History

Bank of New York Mellon’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.7K Buy
+18,664
New +$11.6K ﹤0.01% 4255
2025
Q2 		– Sell
-27,324
Closed -$33.3K – 4233
2025
Q1 		$33.3K Sell
27,324
-2,440
-8% -$4.28K ﹤0.01% 4073
2024
Q4 		$56.3K Buy
29,764
+9,211
+45% +$37.9K ﹤0.01% 4070
2024
Q3 		$110K Buy
20,553
+193
+0.9% +$1.41K ﹤0.01% 4001
2024
Q2 		$150K Buy
20,360
+377
+2% +$3.03K ﹤0.01% 3988
2024
Q1 		$239K Sell
19,983
-1,745
-8% -$14.1K ﹤0.01% 3879
2023
Q4 		$171K Hold
21,728
– – ﹤0.01% 3993
2023
Q3 		$96K Sell
21,728
-1,963
-8% -$43.4K ﹤0.01% 4088
2023
Q2 		$824K Buy
23,691
+2,612
+12% +$71.2K ﹤0.01% 3322
2023
Q1 		$460K Buy
21,079
+3,199
+18% +$71.6K ﹤0.01% 3534
2022
Q4 		$386K Sell
17,880
-15
-0.1% -$326 ﹤0.01% 3682
2022
Q3 		$437K Buy
17,895
+1,298
+8% +$30.2K ﹤0.01% 3641
2022
Q2 		$339K Sell
16,597
-24
-0.1% -$690 ﹤0.01% 3819
2022
Q1 		$592K Buy
16,621
+2,081
+14% +$65K ﹤0.01% 3612
2021
Q4 		$395K Buy
14,540
+246
+2% +$8.78K ﹤0.01% 3945
2021
Q3 		$621K Buy
14,294
+2,670
+23% +$129K ﹤0.01% 3676
2021
Q2 		$578K Buy
11,624
+6,865
+144% +$318K ﹤0.01% 3703
2021
Q1 		$214K Sell
4,759
-417
-8% -$16K ﹤0.01% 4031
2020
Q4 		$135K Buy
5,176
+2,633
+104% +$55K ﹤0.01% 4045
2020
Q3 		$37K Hold
2,543
– – ﹤0.01% 4050
2020
Q2 		$66K Hold
2,543
– – ﹤0.01% 3944
2020
Q1 		$31K Buy
+2,543
New +$42.2K ﹤0.01% 4019

Other funds holding OTLK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

Bank of New York Mellon's OTLK Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 18,664 shares worth $29.7K. The stake represents ﹤0.01% of the portfolio and ranks #4255 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in OTLK as recently as Q1 2025.

Bank of New York Mellon first reported a position in OTLK in Q1 2020 and has held it in 22 quarters since. The position peaked at $824K in Q2 2023. 35 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Bank of New York Mellon held 18,664 shares of Outlook Therapeutics worth $29.7K as of Q2 2026.
  • Outlook Therapeutics was a new Bank of New York Mellon position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4255 holding.
  • Bank of New York Mellon first reported a position in Outlook Therapeutics in Q1 2020 and has held it in 22 quarters since.
  • Bank of New York Mellon's Outlook Therapeutics position peaked at $824K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.